세계의 치과용 골이식 대체물 시장 : 유형별(이종이식편, 동종이식편, 합성 골이식편, 알로플라스트), 용도별(사이너스 리프트, 릿지 증강, 소켓 보존), 제품별(BioOss, Osteograf, Grafton), 최종사용자별, 지역별 - 예측(-2029년)

Dental Bone Graft Substitutes Market by Type (Xenograft, Allograft, Synthetic Bone Grafts, Alloplast), Application (Sinus Lift, Ridge Augumentation, Socket Preservation), Product (BioOss, Osteograf, Grafton), End User, Region- Global Forecast to 2029

US $ 4,950 ￦ 7,024,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 6,650 ￦ 9,437,000

PDF (5-user License)

PDF 보고서를 동일 사업장에서 5명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 8,150 ￦ 11,565,000

PDF (Corporate License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 이용 인원에 제한은 없으나, 국내에 있는 사업장만 해당되며, 해외 지점 등은 포함되지 않습니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 10,000 ￦ 14,191,000

PDF (Global License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. (100% 자회사는 동일 기업으로 간주됩니다.) 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

세계 치과용 골이식 대체물 시장 규모는 2024년 13억 달러에서 예측 기간 동안 7.7%의 CAGR을 기록하며 2029년에는 18억 달러 규모로 성장할 것으로 예상됩니다.

조사 범위
조사 대상 연도	2022-2029년
기준 연도	2023년
예측 기간	2024-2029년
단위	금액(달러)
부문	유형, 용도, 메커니즘, 제품, 최종사용자, 지역
대상 지역	아시아태평양, 북미, 중남미, 중동 및 아프리카 및 GCC 국가

노인 인구가 증가함에 따라 치아 상실과 턱뼈의 노화로 인해 뼈 이식이 필요할 수 있는 치아 손실이 증가하고 있습니다. 치과용 임플란트는 자연스럽고 기능적인 치아를 대체할 수 있는 옵션을 제공하며, 임플란트 식립을 지원하기 위한 뼈 이식에 대한 수요를 촉진하여 시장 성장에 기여하고 있습니다. 반면, 엄격한 규제 준수와 공급망 관리의 복잡성은 이 시장의 성장을 어느 정도 제한할 것으로 예상됩니다.

기전별로는 골전도 부문이 시장에서 가장 높은 CAGR을 보일 것으로 예상됩니다.

골전도 재료의 발전으로 더 작고 다루기 쉬운 골이식편 입자를 개발할 수 있게 되었습니다. 이를 통해 최소 침습적 뼈 이식을 용이하게 하고 환자의 회복을 앞당길 수 있습니다. 또한 골전도 재료는 뼈 세포가 성장할 수 있는 발판과 틀을 제공하여 신체의 자연적 뼈 치유 과정을 자극하고 새로운 뼈 조직 형성을 촉진합니다.

용도별로는 사이너스 리프트 부문이 가장 높은 CAGR을 보일 것으로 예상됩니다.

치과용 대체 골이식편은 치조골 리프트 시술에서 중요한 역할을 합니다. 예를 들어, 자가골 이식은 환자 자신의 뼈를 사용하며, 보통 경골, 고관절, 턱, 턱뼈에서 채취합니다. 자가골 이식은 골 형성에 큰 잠재력을 가지고 있지만, 기증 부위의 부족과 뼈 공급의 제약이 있을 수 있습니다.

유형별로는 합성 골이식편 부문이 가장 높은 CAGR을 보일 것으로 예상됩니다.

합성 골이식편은 일반적으로 하이드록시아파타이트(천연 뼈의 미네랄 성분과 유사), 인산칼슘, 바이오폴리머와 같은 생체적합성 재료로 구성됩니다. 이러한 재료는 뼈의 성장을 위한 발판을 제공하고 이식 부위에서 새로운 뼈 형성을 촉진합니다.

제품별로는 BioOss가 가장 높은 CAGR을 보일 것으로 예상됩니다.

Bio-Oss는 뼈 세포가 이동, 부착 및 증식할 수 있는 틀을 제공하여 뼈의 재생을 촉진하며, Bio-Oss의 주성분은 특허받은 방식으로 가공된 소 해면골 입자로, 미네랄 구조를 유지하면서 유기물을 제거합니다. 이를 통해 인체 뼈를 충실하게 모방한 생체적합성 높은 스캐폴드를 만들어 신생 뼈 합성에 최적의 환경을 조성합니다.

세계의 치과용 골이식재 시장을 조사했으며, 시장 개요, 시장 영향요인 및 시장 기회 분석, 기술·특허 동향, 규제 환경, 사례 연구, 시장 규모 추정 및 예측, 각종 부문별·지역별·주요 국가별 상세 분석, 경쟁 구도, 주요 기업 개요 등의 정보를 전해드립니다.

목차

제1장 소개

제2장 조사 방법

제3장 주요 요약

제4장 주요 인사이트

제5장 시장 개요

• 시장 역학
  • 성장 촉진요인
  • 성장 억제요인
  • 기회
  • 과제

제6장 업계 동향

• 산학 제휴 증가
• 미국과 영국의 치과 의료에 대한 높은 투자 활동
• 기술 분석
  • 가스리스 스프레이 팁 기술
• 바이오세라믹스
• 가격 분석
• 관세와 규제 상황
• 규제기관, 정부기관, 기타 조직
• 밸류체인 분석
• Porter's Five Forces 분석
• 공급망 분석
• 무역 분석
• 특허 분석
• 치과용 골이식 대체물 특허 공개 동향
• 관할 분석 : 치과용 골이식 대체물 시장의 특허 출원 상위자
• 사례 연구
• 주요 회의와 이벤트
• 주요 이해관계자와 구입 기준
• 생태계/시장 맵
• 인접 시장 분석
• 고객의 비즈니스에 영향을 미치는 동향/디스럽션
• 치과용 골이식 대체물 시장 : 미충족 수요
• 치과용 골이식 대체물 시장에서 AI의 역할
• 투자/벤처 캐피털

제7장 치과용 골이식 대체물 시장 : 용도별

• 소켓 보존
• 릿지 증강
• 치주결손 재생
• 임플란트 뼈 재생
• 사이너스 리프트

제8장 치과용 골이식 대체물 시장 : 최종사용자별

• 병원
• 치과의원
• 기타

제9장 치과용 골이식 대체물 시장 : 메커니즘별

• 골전도
• 골유도
• 골촉진
• 골형성

제10장 치과용 골이식 대체물 시장 : 제품별

• BioOss
• Osteograf
• Grafton
• 기타 제품

제11장 치과용 골이식 대체물 시장 : 유형별

• 합성 골이식편
• 이종이식편
• 동종이식편
• 자가이식편
• 알로플라스트
• 탈회 동종이식편
• 기타 유형

제12장 치과용 골이식 대체물 시장 : 지역별

• 북미
• 유럽
• 아시아태평양
• 라틴아메리카
• 중동 및 아프리카
• GCC 국가

제13장 경쟁 상황

• 주요 시장 동향
• 주요 기업의 전략
• 주요 시장 기업 매출 분석
• 시장 점유율 분석
• 경쟁 상황과 동향
• 기업 평가 매트릭스 : 주요 기업
• 기업 평가 매트릭스 : 스타트업/중소기업
• 브랜드/제품 비교 분석
• 주요 기업 R&D비
• 투자 상황
• 치과용 골이식 대체물 시장 평가와 재무 매트릭스

제14장 기업 개요

• 주요 기업
  • DENTSPLY SIRONA INC.
  • ENVISTA HOLDINGS CORPORATION
  • JOHNSON & JOHNSON
  • INSTITUT STRAUMANN AG
  • MEDTRONIC, PLC
  • ZIMVIE INC.
  • HENRY SCHEIN, INC.
  • RTI SURGICAL
  • LIFENET HEALTH
  • DENTIUM CO., LTD.
  • GEISTLICH PHARMA AG
  • STRYKER CORPORATION
  • INTEGRA LIFESCIENCES HOLDINGS CORPORATION
  • TISSUE REGENIX GROUP PLC
  • KURARAY CO., LTD.
  • BEGO GMBH & CO. KG
  • YOUNG INNOVATIONS
  • KEYSTONE DENTAL
• 기타 기업
  • NOVABONE
  • BOTISS BIOMATERIALS GMBH
  • REGENITY
  • OSTEOGENICS BIOMEDICAL
  • HANNOX INTERNATIONAL CORP.
  • MEYER-HAAKE GMBH
  • AROA BIOSURGERY LTD.

제15장 부록

ksm

영문 목차

영문목차

The global dental bone graft substitute market is projected to reach USD 1.8 billion in 2029 from USD 1.3 billion in 2024, at a CAGR of 7.7% between 2024 and 2029.

Scope of the Report
Years Considered for the Study	2022-2029
Base Year	2023
Forecast Period	2024-2029
Units Considered	Value (USD) Billion
Segments	Dental bone graft substitute - Type, Application, Mechanism, Product, End User and Region
Regions covered	Asia Pacific, North America, Europe, Latin America, and the Middle East and Africa and GCC countries

The growing elderly population is more susceptible to tooth loss and jawbone deterioration, potentially requiring bone grafting procedures. Dental implants offer a natural-looking and functional tooth replacement option, driving the demand for bone grafts to support implant placement which further contributes to market growth. On the other hand, stringent regulatory compliance and complexities in supply chain management are expected to limit market growth to a certain extent.

"Based on the mechanism, the osteoconduction segment is expected to grow by the highest CAGR in the dental bone graft substitute market."

Advancements in osteoconductive materials allow for the development of smaller and more manageable bone graft particles. This facilitates minimally invasive surgical techniques for bone grafting procedures, leading to faster patient recovery also osteoconductive materials provide a scaffold or framework for bone cells to grow on and migrate into. This stimulates the body's natural bone healing process, promoting the formation of new bone tissue which is expected to drive the market growth.

"The sinus lift segment in application segment is expected to grow with the highest CAGR in the dental bone graft substitute market."

Dental bone graft substitutes play a crucial role in sinus lift procedures, a surgical technique used to increase jawbone height in the upper jaw before dental implant placement which is expected to drive the market growth. For instance, In autografts, the patient's own bone is used, usually from the tibia, hip, chin, or jaw. Even while autografts have a great potential for osteogenesis, their use can result in donor site morbidity and limited bone supply.

"Based on the type, synthetic bone graft segment is expected to grow by the highest CAGR in the dental bone graft substitute market.

Synthetic bone grafts are typically composed of biocompatible materials like hydroxyapatite (similar to the mineral component of natural bone), calcium phosphates, or biopolymers. These materials provide a scaffold for bone ingrowth, promoting new bone formation at the graft site which is expected to drive the dental bone graft substitute market.

"Based on the product, bio OSS segment is expected to grow by the highest CAGR in the dental bone graft substitute market.

Bio-Oss provides a framework for bone cells to migrate, attach, and proliferate, promoting bone regeneration, Bio-Oss is used to augment the jawbone ridge before dental implant placement, providing a strong foundation for the implant which is expected to drive the dental bone graft substitute market. The main ingredient of Bio-Oss is processed bovine cancellous bone particles through a patented method that eliminates organic materials while maintaining the mineral structure. As a result, a biocompatible scaffold that closely mimics human bone is created, creating the perfect setting for the synthesis of new bone.

"Based on the end user, hospital segment is expected to grow by the highest CAGR in the dental bone graft substitute market.

Dental bone graft substitutes are increasingly valuable tools in hospital dentistry, offering a range of benefits for patients undergoing dental implant procedures, oral surgery, and treatments for jawbone defects. As technology advances and costs become more manageable, these materials are likely to play an even more prominent role in improving patient outcomes and expanding treatment options which is expected to drive the dental bone graft substitute market.

"North America to grow with the second highest CAGR in the dental bone graft substitute market during the forecast period."

The growing elderly population in North America is more susceptible to tooth loss and jawbone deterioration, potentially requiring bone grafting procedures to support dental implants or other restorative treatments are fueling the expansion of the dental bone graft substitute market in North America.

Europe was the second largest segment in the dental bone graft substitute market in 2023. The Germany accounted for the larger share of the European dental bone graft substitute market in 2023. The rising number of dental disorders and and growing awareness regarding dental bone graft substitute is expected to drive the market growth in Europen market.

A breakdown of the primary participants (supply-side) for the dental bone graft substitute market referred to for this report is provided below:

• By Company Type: Tier 40%, Tier 35%, and Tier 25%
• By Designation: C-level-30%, Director Level-55%, and Others-15%
• By Region: North America-20%, Europe-15%, Asia Pacific-25%, Latin America- 10%, Middle East & Africa-30%.

Prominent players in the dental bone graft substitute market include Dentsply Sirona Inc. (US), Envista Holdings Corporation (US), JOHNSON & JOHNSON (US), Stryker Corporation (US), Medtronic, Plc (Ireland), Institut Straumann AG (Switzerland), Zimvie Inc. (US), Henry Schein Inc. (US), RTI Surgical Holdings Inc.(US), Lifenet Health (US), Dentium (US), Geistlich Pharma AG (Switzerland), Integra Lifesciences Holdings Corporation (US), Tissue Regenix Group (UK), Kuraray Co. Ltd. (Japan), BEGO GmbH & Co. KG (Germany), Young Innovations (US), Keystone Dental (US), Novabone LLC. (US), Biotiss Biomaterials LLC (US), Collagen Matrix Inc.(US), Osteogenics Biomedical (US), Hannox International Corp.(Taiwan), Meyer Haake GMBH (Germany) and Arora Biosurgery Ltd. (New Zealand).

Research Coverage:

The report analyzes the dental bone graft substitute market and aims at estimating the market size and future growth potential of this market based on various segments such as type, application, mechanism, product, end user and region. The report also includes a competitive analysis of the key players in this market along with their company profiles, product/service offerings, recent developments, and key market strategies.

Reasons to Buy the Report

The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall dental bone graft substitute market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.

This report provides insights into the following pointers:

• Analysis of key drivers (growing market for dental tourism in emerging countries, increasing disposable income in developing counties, rising cases of dental caries and the subsequent increase in tooth repair procedures, changing demographics), restraints (lack of proper reimbursement scenario, stringent regulations pertaining to medical devices used in dentistry, dearth of trained dental practitioners), opportunities (increasing demand from customers and rising inclination towards cosmetic dentistry, low penetration rates for dental bone graft substitutes, consolidation of dental practices and rising dso activity, growing demand for bone graft substitutes from emerging markets) and challenges (pricing pressure faced by prominent market players)
• Market Penetration: It includes extensive information on product portfolios offered by the major players in the global dental bone graft substitute market. The report includes various segments in market type, application, mechanism, product, end user and region
• Product Enhancement/Innovation: Comprehensive details about new product launches and anticipated trends in the global dental bone graft substitute market.
• Market Development: Thorough knowledge and analysis of the profitable rising markets type, application, mechanism, product, end user and region
• Market Diversification: Comprehensive information about newly launched product and services, expanding markets, current advancements, and investments in the global dental bone graft substitute market.
• Competitive Assessment: Thorough evaluation of the market shares, growth plans, offerings of product and services, and capacities of the major competitors in the global dental bone graft substitute market.

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 STUDY OBJECTIVES
• 1.2 MARKET DEFINITION
• 1.3 STUDY SCOPE
  • 1.3.1 MARKET SEGMENTATION
  • 1.3.2 REGIONS COVERED
• 1.4 YEARS CONSIDERED
• 1.5 CURRENCY CONSIDERED
  • TABLE 1 STANDARD CURRENCY CONVERSION RATES, 2018-2022
• 1.6 KEY STAKEHOLDERS
• 1.7 SUMMARY OF CHANGES
  • 1.7.1 RECESSION IMPACT

2 RESEARCH METHODOLOGY

• 2.1 RESEARCH DATA
  • FIGURE 1 RESEARCH DESIGN
  • 2.1.1 SECONDARY DATA
    • 2.1.1.1 Key data from secondary sources
  • 2.1.2 PRIMARY DATA
  • FIGURE 2 KEY PRIMARY SOURCES
    • 2.1.2.1 Key data from primary sources
    • 2.1.2.2 Key industry insights
  • FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
  • FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END USER, DESIGNATION, AND REGION
• 2.2 MARKET SIZE ESTIMATION
  • FIGURE 6 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
  • FIGURE 7 REVENUE SHARE ANALYSIS: ILLUSTRATIVE EXAMPLE OF TISSUE REGENIX GROUP PLC
  • FIGURE 8 DENTAL BONE GRAFT SUBSTITUTES MARKET: SUPPLY-SIDE MARKET SIZE ESTIMATION
  • FIGURE 9 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 10 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
  • FIGURE 11 TOP-DOWN APPROACH
• 2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
  • FIGURE 12 DATA TRIANGULATION METHODOLOGY
• 2.4 RESEARCH ASSUMPTIONS
• 2.5 LIMITATIONS
  • 2.5.1 METHODOLOGY-RELATED LIMITATIONS
• 2.6 RISK ASSESSMENT
• 2.7 IMPACT OF RECESSION

3 EXECUTIVE SUMMARY

• FIGURE 13 SYNTHETIC BONE GRAFT SEGMENT TO LEAD MARKET BY 2029
• FIGURE 14 SOCKET PRESERVATION SEGMENT TO ACCOUNT FOR LARGEST SHARE IN 2024
• FIGURE 15 OSTEOCONDUCTION SEGMENT TO LEAD MARKET BY 2029
• FIGURE 16 BIO-OSS SEGMENT TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD
• FIGURE 17 HOSPITALS SEGMENT TO ACCOUNT FOR LARGEST SHARE BY 2029
• FIGURE 18 DENTAL BONE GRAFT SUBSTITUTES MARKET: REGIONAL SNAPSHOT

4 PREMIUM INSIGHTS

• 4.1 OPPORTUNITIES FOR PLAYERS IN DENTAL BONE GRAFT SUBSTITUTES MARKET
  • FIGURE 19 RISING TECHNOLOGICAL ADVANCEMENTS TO DRIVE GROWTH OF DENTAL BONE GRAFT SUBSTITUTES MARKET
• 4.2 NORTH AMERICA: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY END USER
  • FIGURE 20 HOSPITALS SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD
• 4.3 DENTAL BONE GRAFT SUBSTITUTES MARKET: GEOGRAPHIC SNAPSHOT
  • FIGURE 21 ASIA PACIFIC TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD
• 4.4 DENTAL BONE GRAFT SUBSTITUTES MARKET: REGIONAL MIX
  • FIGURE 22 NORTH AMERICA TO BE LARGEST MARKET FOR DENTAL BONE GRAFT SUBSTITUTES DURING FORECAST PERIOD
• 4.5 DENTAL BONE GRAFT SUBSTITUTES MARKET: DEVELOPED VS. DEVELOPING MARKETS
  • FIGURE 23 DEVELOPING MARKETS TO REGISTER HIGHER GROWTH DURING FORECAST PERIOD

5 MARKET OVERVIEW

• 5.1 INTRODUCTION
• 5.2 MARKET DYNAMICS
  • FIGURE 24 DENTAL BONE GRAFT SUBSTITUTES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • 5.2.1 DRIVERS
    • 5.2.1.1 Growing market for dental tourism in emerging countries
    • 5.2.1.2 Increasing disposable income in developing countries
    • 5.2.1.3 Rising cases of dental caries and subsequent increase in tooth repair procedures
    • 5.2.1.4 Changing demographics
  • 5.2.2 RESTRAINTS
    • 5.2.2.1 Lack of proper reimbursement scenario
    • 5.2.2.2 Stringent regulations pertaining to medical devices used in dentistry
    • 5.2.2.3 Dearth of trained dental practitioners
  • 5.2.3 OPPORTUNITIES
    • 5.2.3.1 Increasing demand from customers and rising inclination toward cosmetic dentistry
    • 5.2.3.2 Low penetration rates for dental bone graft substitutes
    • 5.2.3.3 Consolidation of dental practices and rising DSO activity
    • 5.2.3.4 Growing demand for bone graft substitutes from emerging markets
  • 5.2.4 CHALLENGES
    • 5.2.4.1 Pricing pressure faced by prominent market players

6 INDUSTRY TRENDS

• 6.1 RISING NUMBER OF INDUSTRY-ACADEMIA COLLABORATIONS
• 6.2 HIGH INVESTMENT ACTIVITY IN DENTAL PRACTICES IN US AND UK
  • TABLE 2 EXAMPLES OF RECENT DEALS BACKED BY PRIVATE EQUITY IN US, 2020-2023
• 6.3 TECHNOLOGY ANALYSIS
  • 6.3.1 GASLESS SPRAY TIP TECHNOLOGY
• 6.4 BIO CERAMICS
• 6.5 PRICING ANALYSIS
  • TABLE 3 AVERAGE SELLING PRICE TREND FOR KEY TYPES OF DENTAL BONE GRAFT SUBSTITUTES, BY REGION, 2021 (USD)
  • TABLE 4 AVERAGE SELLING PRICE TREND FOR KEY TYPES OF DENTAL BONE GRAFT SUBSTITUTES, BY REGION, 2022 (USD)
• 6.6 TARIFF AND REGULATORY LANDSCAPE
  • 6.6.1 REGULATORY ANALYSIS
    • 6.6.1.1 US
    • 6.6.1.2 European Union
    • 6.6.1.3 China
• 6.7 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 5 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 6 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 7 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
• 6.8 VALUE CHAIN ANALYSIS
  • FIGURE 25 VALUE CHAIN ANALYSIS
• 6.9 PORTER'S FIVE FORCES ANALYSIS
  • TABLE 8 PORTER'S FIVE FORCES ANALYSIS
  • 6.9.1 THREAT OF NEW ENTRANTS
  • 6.9.2 THREAT OF SUBSTITUTES
  • 6.9.3 BARGAINING POWER OF SUPPLIERS
  • 6.9.4 BARGAINING POWER OF BUYERS
  • 6.9.5 INTENSITY OF COMPETITIVE RIVALRY
• 6.10 SUPPLY CHAIN ANALYSIS
  • FIGURE 26 SUPPLY CHAIN ANALYSIS
• 6.11 TRADE ANALYSIS
  • TABLE 9 VALUE OF INSTRUMENTS AND APPLIANCES USED IN MEDICAL, SURGICAL, DENTAL, OR VETERINARY SCIENCES EXPORTED FROM US, 2019-2022 (000')
• 6.12 PATENT ANALYSIS
• 6.13 PATENT PUBLICATION TRENDS FOR DENTAL BONE GRAFT SUBSTITUTES
  • FIGURE 27 PATENT PUBLICATION TRENDS (JANUARY 2013-SEPTEMBER 2023)
• 6.14 JURISDICTION ANALYSIS: TOP APPLICANTS FOR PATENTS IN DENTAL BONE GRAFT SUBSTITUTES MARKET
  • FIGURE 28 TOP PATENT APPLICANTS AND OWNERS (COMPANIES/INSTITUTES) FOR DENTAL BONE GRAFT SUBSTITUTES (JANUARY 2013-MARCH 2024)
  • FIGURE 29 TOP PATENT APPLICANT COUNTRIES FOR DENTAL BONE GRAFT SUBSTITUTES (JANUARY 2013-MARCH 2024)
• 6.15 CASE STUDIES
  • 6.15.1 IDENTIFYING PREFERRED ANTIMICROBIAL AGENTS AND COATING SUBSTANCES USED FOR IMPLANT COATINGS
  • 6.15.2 ANALYZING SHARE OF RADIOGRAPHY SYSTEMS IN DENTISTRY MARKET
• 6.16 KEY CONFERENCES & EVENTS
  • TABLE 10 DETAILED LIST OF CONFERENCES & EVENTS
• 6.17 KEY STAKEHOLDERS & BUYING CRITERIA
  • 6.17.1 KEY STAKEHOLDERS IN BUYING PROCESS
  • FIGURE 30 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE APPLICATIONS
  • TABLE 11 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE APPLICATIONS
  • 6.17.2 BUYING CRITERIA
  • FIGURE 31 KEY BUYING CRITERIA FOR TOP THREE APPLICATIONS
• 6.18 ECOSYSTEM/MARKET MAP
  • FIGURE 32 ECOSYSTEM/MARKET MAP
  • 6.18.1 ROLE OF PLAYERS IN MARKET ECOSYSTEM
• 6.19 ADJACENT MARKET ANALYSIS
  • FIGURE 33 DENTAL BONE GRAFT SUBSTITUTES MARKET: ADJACENT MARKETS
• 6.20 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
  • FIGURE 34 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
• 6.21 DENTAL BONE GRAFT SUBSTITUTES MARKET: UNMET NEEDS
• 6.22 ROLE OF ARTIFICIAL INTELLIGENCE (AI) IN DENTAL BONE GRAFT SUBSTITUTES MARKET
• 6.23 INVESTMENT/VENTURE CAPITAL

7 DENTAL BONE GRAFT SUBSTITUTES MARKET, BY APPLICATION

• 7.1 INTRODUCTION
  • TABLE 12 DENTAL BONE GRAFT SUBSTITUTES MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
• 7.2 SOCKET PRESERVATION
  • 7.2.1 SOCKET PRESERVATION REDUCES BONE LOSS AFTER TOOTH EXTRACTION
  • TABLE 13 SOCKET PRESERVATION: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY COUNTRY/REGION, 2022-2029 (USD MILLION)
• 7.3 RIDGE AUGMENTATION
  • 7.3.1 RIDGE AUGMENTATION RECREATES NATURAL CONTOUR OF GUMS AND JAW
  • TABLE 14 RIDGE AUGMENTATION: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY COUNTRY/REGION, 2022-2029 (USD MILLION)
• 7.4 PERIODONTAL DEFECT REGENERATION
  • 7.4.1 CHANGES IN LIFESTYLE AND EATING HABITS TO LEAD TO USE OF DENTAL BONE GRAFT SUBSTITUTES FOR PERIODONTAL DEFECT REGENERATION
  • TABLE 15 PERIODONTAL DEFECT REGENERATION: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY COUNTRY/REGION, 2022-2029 (USD MILLION)
• 7.5 IMPLANT BONE REGENERATION
  • 7.5.1 UTILIZATION OF GUIDED BONE REGENERATION MEMBRANES FACILITATES HEALING OF GRAFTED MATERIAL
  • TABLE 16 IMPLANT BONE REGENERATION: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY COUNTRY/REGION, 2022-2029 (USD MILLION)
• 7.6 SINUS LIFT
  • 7.6.1 SINUS AUGMENTATION RAISES SINUS FLOOR AND DEVELOPS BONE FOR PLACEMENT OF DENTAL IMPLANTS
  • TABLE 17 SINUS LIFT: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY COUNTRY/REGION, 2022-2029 (USD MILLION)

8 DENTAL BONE GRAFT SUBSTITUTES MARKET, BY END USER

• 8.1 INTRODUCTION
  • TABLE 18 DENTAL BONE GRAFT SUBSTITUTES MARKET, BY END USER, 2022-2029 (USD MILLION)
• 8.2 HOSPITALS
  • 8.2.1 INCREASING NUMBER OF COSMETIC DENTISTRY PROCEDURES ACROSS HOSPITALS TO DRIVE MARKET GROWTH
  • TABLE 19 HOSPITALS: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY COUNTRY/REGION, 2022-2029 (USD MILLION)
• 8.3 DENTAL CLINICS
  • 8.3.1 HIGH-QUALITY SERVICES RENDERED BY DENTAL CLINICS' STAFF TO DRIVE MARKET GROWTH
  • TABLE 20 NUMBER OF DENTAL CLINICS, BY COUNTRY, 2020 VS. 2022
  • TABLE 21 DENTAL CLINICS: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY COUNTRY/REGION, 2022-2029 (USD MILLION)
• 8.4 OTHER END USERS
  • TABLE 22 OTHER END USERS: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY COUNTRY/REGION, 2022-2029 (USD MILLION)

9 DENTAL BONE GRAFT SUBSTITUTES MARKET, BY MECHANISM

• 9.1 INTRODUCTION
  • TABLE 23 DENTAL BONE GRAFT SUBSTITUTES MARKET, BY MECHANISM, 2022-2029 (USD MILLION)
• 9.2 OSTEOCONDUCTION
  • 9.2.1 OSTEOCONDUCTION SERVES AS SCAFFOLD FOR BONE CELLS TO ATTACH, MIGRATE, GROW, AND DIVIDE
  • TABLE 24 OSTEOCONDUCTION: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY COUNTRY/REGION, 2022-2029 (USD MILLION)
• 9.3 OSTEOINDUCTION
  • 9.3.1 OSTEOINDUCTION FACILITATES BONE HEALING PROCESS
  • TABLE 25 OSTEOINDUCTION: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY COUNTRY/REGION, 2022-2029 (USD MILLION)
• 9.4 OSTEOPROMOTION
  • 9.4.1 OSTEOPROMOTION INVOLVES ENHANCEMENT OF OSTEOINDUCTION WITHOUT POSSESSION OF OSTEOINDUCTIVE PROPERTIES
  • TABLE 26 OSTEOPROMOTION: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY COUNTRY/REGION, 2022-2029 (USD MILLION)
• 9.5 OSTEOGENESIS
  • 9.5.1 OSTEOGENESIS PLAYS CRUCIAL ROLE IN FACILITATING SUCCESSFUL BONE REGENERATION AND REPAIR
  • TABLE 27 OSTEOGENESIS: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY COUNTRY/REGION, 2022-2029 (USD MILLION)

10 DENTAL BONE GRAFT SUBSTITUTES MARKET, BY PRODUCT

• 10.1 INTRODUCTION
  • TABLE 28 DENTAL BONE GRAFT SUBSTITUTES MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
• 10.2 BIO-OSS
  • 10.2.1 HIGH IMPLANT SURVIVAL RATES ASSOCIATED WITH BIO-OSS PRODUCTS TO DRIVE MARKET GROWTH
  • TABLE 29 BIO-OSS: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY COUNTRY/REGION, 2022-2029 (USD MILLION)
• 10.3 OSTEOGRAF
  • 10.3.1 NON-POROUS AND RESORBABLE NATURE OF OSTEOGRAF TO DRIVE MARKET GROWTH
  • TABLE 30 OSTEOGRAF: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY COUNTRY/REGION, 2022-2029 (USD MILLION)
• 10.4 GRAFTON
  • 10.4.1 INCREASED SAFETY AND LIMITED POSSIBILITY OF DISEASE TRANSMISSION TO BOOST DEMAND FOR GRAFTON
  • TABLE 31 GRAFTON: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY COUNTRY/REGION, 2022-2029 (USD MILLION)
• 10.5 OTHER PRODUCTS
  • TABLE 32 OTHER PRODUCTS: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY COUNTRY/REGION, 2022-2029 (USD MILLION)

11 DENTAL BONE GRAFT SUBSTITUTES MARKET, BY TYPE

• 11.1 INTRODUCTION
  • TABLE 33 DENTAL BONE GRAFT SUBSTITUTES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• 11.2 SYNTHETIC BONE GRAFT
  • 11.2.1 INCREASING TECHNOLOGICAL ADVANCEMENTS TO INCREASE ADOPTION OF SYNTHETIC BONE GRAFT
  • TABLE 34 SYNTHETIC BONE GRAFT: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY COUNTRY/REGION, 2022-2029 (USD MILLION)
• 11.3 XENOGRAFT
  • 11.3.1 TECHNOLOGICAL ADVANCEMENTS IN USE OF XENOGRAFT MATERIALS AND SCARCITY OF ALLOGRAFT MATERIALS TO DRIVE MARKET
  • TABLE 35 XENOGRAFT: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY COUNTRY/REGION, 2022-2029 (USD MILLION)
• 11.4 ALLOGRAFT
  • 11.4.1 INCREASED OPERATING TIMELINES AND POTENTIAL COMPLICATIONS AND MORBIDITY OF HARVEST SITE TO BOOST USE OF ALLOGRAFT
  • TABLE 36 ALLOGRAFT: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY COUNTRY/REGION, 2022-2029 (USD MILLION)
• 11.5 AUTOGRAFT
  • 11.5.1 LITTLE SCOPE FOR DISEASE TRANSMISSION FROM GRAFT MATERIALS TO DRIVE ADOPTION OF AUTOGRAFT
  • TABLE 37 AUTOGRAFT: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY COUNTRY/REGION, 2022-2029 (USD MILLION)
• 11.6 ALLOPLAST
  • 11.6.1 ALLOPLAST MATERIALS PROMOTE BONE HEALING THROUGH OSTEOCONDUCTION
  • TABLE 38 ALLOPLAST: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY COUNTRY/REGION, 2022-2029 (USD MILLION)
• 11.7 DEMINERALIZED ALLOGRAFT
  • 11.7.1 DEMINERALIZED ALLOGRAFT POSSESSES MORE OSTEOINDUCTIVE PROPERTIES THAN REGULAR ALLOGRAFT
  • TABLE 39 DEMINERALIZED ALLOGRAFT: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY COUNTRY/REGION, 2022-2029 (USD MILLION)
• 11.8 OTHER TYPES
  • TABLE 40 OTHER TYPES: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY COUNTRY/REGION, 2022-2029 (USD MILLION)

12 DENTAL BONE GRAFT SUBSTITUTES MARKET, BY REGION

• 12.1 INTRODUCTION
  • FIGURE 35 US TO DOMINATE DENTAL BONE GRAFT SUBSTITUTES MARKET DURING FORECAST PERIOD
  • TABLE 41 DENTAL BONE GRAFT SUBSTITUTES MARKET, BY COUNTRY/REGION, 2022-2029 (USD MILLION)
• 12.2 NORTH AMERICA
  • TABLE 42 US: DENTAL EXPENDITURE, 2011-2020
  • 12.2.1 NORTH AMERICA: RECESSION IMPACT ANALYSIS
  • FIGURE 36 NORTH AMERICA: DENTAL BONE GRAFT SUBSTITUTES MARKET SNAPSHOT
  • TABLE 43 NORTH AMERICA: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY COUNTRY/REGION, 2022-2029 (USD MILLION)
  • TABLE 44 NORTH AMERICA: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 45 NORTH AMERICA: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 46 NORTH AMERICA: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 47 NORTH AMERICA: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY MECHANISM, 2022-2029 (USD MILLION)
  • TABLE 48 NORTH AMERICA: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY END USER, 2022-2029 (USD MILLION)
  • 12.2.2 US
    • 12.2.2.1 Increasing patient awareness about advantages of dental bone graft substitutes over traditional treatments to boost growth
  • TABLE 49 US: MACROECONOMIC INDICATORS
  • TABLE 50 US: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 51 US: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 52 US: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 53 US: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY MECHANISM, 2022-2029 (USD MILLION)
  • TABLE 54 US: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY END USER, 2022-2029 (USD MILLION)
  • 12.2.3 CANADA
    • 12.2.3.1 Rising geriatric population to propel market expansion
  • TABLE 55 CANADA: MACROECONOMIC INDICATORS
  • TABLE 56 CANADA: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 57 CANADA: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 58 CANADA: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 59 CANADA: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY MECHANISM, 2022-2029 (USD MILLION)
  • TABLE 60 CANADA: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY END USER, 2022-2029 (USD MILLION)
• 12.3 EUROPE
  • 12.3.1 EUROPE: RECESSION IMPACT ANALYSIS
  • FIGURE 37 EUROPE: DENTAL BONE GRAFT SUBSTITUTES MARKET SNAPSHOT
  • TABLE 61 EUROPE: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY COUNTRY/REGION, 2022-2029 (USD MILLION)
  • TABLE 62 EUROPE: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 63 EUROPE: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 64 EUROPE: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 65 EUROPE: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY MECHANISM, 2022-2029 (USD MILLION)
  • TABLE 66 EUROPE: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY END USER, 2022-2029 (USD MILLION)
  • 12.3.2 GERMANY
    • 12.3.2.1 Country's robust health insurance system to drive popularity of dental bone graft substitutes
  • TABLE 67 GERMANY: MACROECONOMIC INDICATORS
  • TABLE 68 GERMANY: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 69 GERMANY: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 70 GERMANY: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 71 GERMANY: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY MECHANISM, 2022-2029 (USD MILLION)
  • TABLE 72 GERMANY: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY END USER, 2022-2029 (USD MILLION)
  • 12.3.3 UK
    • 12.3.3.1 Preference for costly procedures due to availability of reimbursement facilities to lead to potential growth
  • TABLE 73 UK: MACROECONOMIC INDICATORS
  • TABLE 74 UK: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 75 UK: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 76 UK: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 77 UK: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY MECHANISM, 2022-2029 (USD MILLION)
  • TABLE 78 UK: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY END USER, 2022-2029 (USD MILLION)
  • 12.3.4 FRANCE
    • 12.3.4.1 Rising awareness among people regarding benefits of dental bone graft substitutes and presence of major players to drive growth
  • TABLE 79 FRANCE: MACROECONOMIC INDICATORS
  • TABLE 80 FRANCE: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 81 FRANCE: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 82 FRANCE: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 83 FRANCE: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY MECHANISM, 2022-2029 (USD MILLION)
  • TABLE 84 FRANCE: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY END USER, 2022-2029 (USD MILLION)
  • 12.3.5 ITALY
    • 12.3.5.1 Intensive R&D and use of sophisticated materials to manufacture advanced products to propel market
  • TABLE 85 ITALY: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 86 ITALY: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 87 ITALY: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 88 ITALY: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY MECHANISM, 2022-2029 (USD MILLION)
  • TABLE 89 ITALY: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY END USER, 2022-2029 (USD MILLION)
  • 12.3.6 SPAIN
    • 12.3.6.1 Government initiatives to provide dental cover to people to boost market
  • TABLE 90 SPAIN: MACROECONOMIC INDICATORS
  • TABLE 91 SPAIN: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 92 SPAIN: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 93 SPAIN: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 94 SPAIN: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY MECHANISM, 2022-2029 (USD MILLION)
  • TABLE 95 SPAIN: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY END USER, 2022-2029 (USD MILLION)
  • 12.3.7 REST OF EUROPE
  • TABLE 96 REST OF EUROPE: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 97 REST OF EUROPE: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 98 REST OF EUROPE: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 99 REST OF EUROPE: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY MECHANISM, 2022-2029 (USD MILLION)
  • TABLE 100 REST OF EUROPE: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY END USER, 2022-2029 (USD MILLION)
• 12.4 ASIA PACIFIC
  • TABLE 101 DENTAL IMPLANTS PER 10,000 PEOPLE AND AVERAGE NUMBER OF IMPLANTS PLACED PER DENTIST, 2020
  • 12.4.1 ASIA PACIFIC: RECESSION IMPACT ANALYSIS
  • FIGURE 38 ASIA PACIFIC: DENTAL BONE GRAFT SUBSTITUTES MARKET SNAPSHOT
  • TABLE 102 ASIA PACIFIC: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY COUNTRY/REGION, 2022-2029 (USD MILLION)
  • TABLE 103 ASIA PACIFIC: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 104 ASIA PACIFIC: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 105 ASIA PACIFIC: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 106 ASIA PACIFIC: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY MECHANISM, 2022-2029 (USD MILLION)
  • TABLE 107 ASIA PACIFIC: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY END USER, 2022-2029 (USD MILLION)
  • 12.4.2 JAPAN
    • 12.4.2.1 Increasing awareness, availability of reimbursement, and growing income levels to offer growth opportunities for market players
  • TABLE 108 JAPAN: MACROECONOMIC INDICATORS
  • TABLE 109 JAPAN: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 110 JAPAN: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 111 JAPAN: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 112 JAPAN: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY MECHANISM, 2022-2029 (USD MILLION)
  • TABLE 113 JAPAN: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY END USER, 2022-2029 (USD MILLION
  • 12.4.3 CHINA
    • 12.4.3.1 Growing geriatric population, economic boom, and increasing per capita income to propel growth
  • TABLE 114 CHINA: MACROECONOMIC INDICATORS
  • TABLE 115 CHINA: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 116 CHINA: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 117 CHINA: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 118 CHINA: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY MECHANISM, 2022-2029 (USD MILLION)
  • TABLE 119 CHINA: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY END USER, 2022-2029 (USD MILLION
  • 12.4.4 INDIA
    • 12.4.4.1 Diverse, lucrative opportunities offered to dental product and service providers to ensure adequate market progress
  • TABLE 120 INDIA: MACROECONOMIC INDICATORS
  • TABLE 121 INDIA: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 122 INDIA: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 123 INDIA: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 124 INDIA: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY MECHANISM, 2022-2029 (USD MILLION)
  • TABLE 125 INDIA: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY END USER, 2022-2029 (USD MILLION
  • 12.4.5 AUSTRALIA
    • 12.4.5.1 Popularity of xenograft and allograft to open new opportunities for growth of market players
  • TABLE 126 AUSTRALIA: ORAL HEALTH STATUS OF CHILDREN AND ADULTS
  • TABLE 127 AUSTRALIA: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 128 AUSTRALIA: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 129 AUSTRALIA: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 130 AUSTRALIA: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY MECHANISM, 2022-2029 (USD MILLION)
  • TABLE 131 AUSTRALIA: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY END USER, 2022-2029 (USD MILLION)
  • 12.4.6 SOUTH KOREA
    • 12.4.6.1 Rising geriatric population and medical tourism to drive market
  • TABLE 132 NUMBER OF FOREIGN PATIENTS VISITING DENTAL FACILITIES IN SOUTH KOREA
  • TABLE 133 SOUTH KOREA: MACROECONOMIC INDICATORS
  • TABLE 134 SOUTH KOREA: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 135 SOUTH KOREA: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 136 SOUTH KOREA: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 137 SOUTH KOREA: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY MECHANISM, 2022-2029 (USD MILLION)
  • TABLE 138 SOUTH KOREA: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY END USER, 2022-2029 (USD MILLION
  • 12.4.7 REST OF ASIA PACIFIC
  • TABLE 139 REST OF ASIA PACIFIC: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 140 REST OF ASIA PACIFIC: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 141 REST OF ASIA PACIFIC: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 142 REST OF ASIA PACIFIC: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY MECHANISM, 2022-2029 (USD MILLION)
  • TABLE 143 REST OF ASIA PACIFIC: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY END USER, 2022-2029 (USD MILLION
• 12.5 LATIN AMERICA
  • 12.5.1 LATIN AMERICA: RECESSION IMPACT ANALYSIS
  • TABLE 144 LATIN AMERICA: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY COUNTRY/REGION, 2022-2029 (USD MILLION)
  • TABLE 145 LATIN AMERICA: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 146 LATIN AMERICA: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 147 LATIN AMERICA: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 148 LATIN AMERICA: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY MECHANISM, 2022-2029 (USD MILLION)
  • TABLE 149 LATIN AMERICA: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY END USER, 2022-2029 (USD MILLION)
  • 12.5.2 BRAZIL
    • 12.5.2.1 Improving healthcare infrastructure and rising investments by leading players to spur demand
  • TABLE 150 BRAZIL: MACROECONOMIC INDICATORS
  • TABLE 151 BRAZIL: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 152 BRAZIL: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 153 BRAZIL: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 154 BRAZIL: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY MECHANISM, 2022-2029 (USD MILLION)
  • TABLE 155 BRAZIL: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY END USER, 2022-2029 (USD MILLION)
  • 12.5.3 MEXICO
    • 12.5.3.1 Rising medical tourism to support market growth
  • TABLE 156 MEXICO: MACROECONOMIC INDICATORS
  • TABLE 157 MEXICO: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 158 MEXICO: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 159 MEXICO: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 160 MEXICO: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY MECHANISM, 2022-2029 (USD MILLION)
  • TABLE 161 MEXICO: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY END USER, 2022-2029 (USD MILLION)
  • 12.5.4 ARGENTINA
    • 12.5.4.1 Growing demand for personalized dentistry to spur market demand
  • TABLE 162 ARGENTINA: MACROECONOMIC INDICATORS
  • TABLE 163 ARGENTINA: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 164 ARGENTINA: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 165 ARGENTINA: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 166 ARGENTINA: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY MECHANISM, 2022-2029 (USD MILLION)
  • TABLE 167 ARGENTINA: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY END USER, 2022-2029 (USD MILLION)
  • 12.5.5 REST OF LATIN AMERICA
  • TABLE 168 REST OF LATIN AMERICA: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 169 REST OF LATIN AMERICA: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 170 REST OF LATIN AMERICA: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 171 REST OF LATIN AMERICA: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY MECHANISM, 2022-2029 (USD MILLION)
  • TABLE 172 REST OF LATIN AMERICA: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY END USER, 2022-2029 (USD MILLION)
• 12.6 MIDDLE EAST & AFRICA
  • 12.6.1 GROWING INVESTMENTS IN DIGITAL HEALTHCARE INDUSTRY TO BOOST DEMAND FOR DENTAL BONE GRAFT SUBSTITUTES
  • 12.6.2 MIDDLE EAST & AFRICA: RECESSION IMPACT ANALYSIS
  • TABLE 173 MIDDLE EAST & AFRICA: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 174 MIDDLE EAST & AFRICA: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 175 MIDDLE EAST & AFRICA: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 176 MIDDLE EAST & AFRICA: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY MECHANISM, 2022-2029 (USD MILLION)
  • TABLE 177 MIDDLE EAST & AFRICA: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY END USER, 2022-2029 (USD MILLION)
• 12.7 GCC COUNTRIES
  • 12.7.1 INCREASING DEMAND FOR HEALTH SERVICES DUE TO POPULATION GROWTH TO DRIVE MARKET FOR DENTAL BONE GRAFT SUBSTITUTES
  • 12.7.2 GCC COUNTRIES: RECESSION IMPACT ANALYSIS
  • TABLE 178 GCC COUNTRIES: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 179 GCC COUNTRIES: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 180 GCC COUNTRIES: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 181 GCC COUNTRIES: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY MECHANISM, 2022-2029 (USD MILLION)
  • TABLE 182 GCC COUNTRIES: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY END USER, 2022-2029 (USD MILLION)

13 COMPETITIVE LANDSCAPE

• 13.1 INTRODUCTION
• 13.2 KEY MARKET DEVELOPMENTS
• 13.3 KEY PLAYERS' STRATEGIES
• 13.4 REVENUE ANALYSIS OF KEY MARKET PLAYERS
  • FIGURE 39 REVENUE SHARE ANALYSIS OF KEY PLAYERS OPERATING IN DENTAL BONE GRAFT SUBSTITUTES MARKET
• 13.5 MARKET SHARE ANALYSIS
  • FIGURE 40 MARKET SHARE ANALYSIS, BY KEY PLAYER, 2023
  • TABLE 183 DENTAL BONE GRAFT SUBSTITUTES MARKET: DEGREE OF COMPETITION
• 13.6 COMPETITIVE SITUATION AND TRENDS
  • 13.6.1 PRODUCT LAUNCHES & APPROVALS
  • TABLE 184 DENTAL BONE GRAFT SUBSTITUTES MARKET: PRODUCT LAUNCHES & APPROVALS, MAY 2020-DECEMBER 2021
  • 13.6.2 DEALS
  • TABLE 185 DENTAL BONE GRAFT SUBSTITUTES MARKET: DEALS, DECEMBER 2022-JANUARY 2024
  • 13.6.3 EXPANSIONS
  • TABLE 186 DENTAL BONE GRAFT SUBSTITUTES MARKET: EXPANSIONS, APRIL 2021
• 13.7 COMPANY EVALUATION MATRIX: KEY PLAYERS
  • 13.7.1 STARS
  • 13.7.2 EMERGING LEADERS
  • 13.7.3 PERVASIVE PLAYERS
  • 13.7.4 EMERGING PLAYERS
  • FIGURE 41 DENTAL BONE GRAFT SUBSTITUTES MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
  • 13.7.5 FOOTPRINT ANALYSIS
  • FIGURE 42 OVERALL COMPANY FOOTPRINT
  • TABLE 187 COMPANY PRODUCT FOOTPRINT
  • TABLE 188 COMPANY APPLICATION FOOTPRINT
  • TABLE 189 COMPANY MECHANISM FOOTPRINT
  • TABLE 190 COMPANY END USER FOOTPRINT
  • TABLE 191 COMPANY REGIONAL FOOTPRINT
• 13.8 COMPANY EVALUATION MATRIX: START-UPS/SMES
  • 13.8.1 PROGRESSIVE COMPANIES
  • 13.8.2 STARTING BLOCKS
  • 13.8.3 RESPONSIVE COMPANIES
  • 13.8.4 DYNAMIC COMPANIES
  • FIGURE 43 DENTAL BONE GRAFT SUBSTITUTES MARKET: COMPANY EVALUATION MATRIX (START-UPS/SMES), 2023
  • 13.8.5 COMPETITIVE BENCHMARKING
  • TABLE 192 DENTAL BONE GRAFT SUBSTITUTES MARKET: DETAILED LIST OF KEY START-UPS/SMES
• 13.9 BRAND/PRODUCT COMPARATIVE ANALYSIS
• 13.10 R&D EXPENDITURE OF KEY PLAYERS
• 13.11 INVESTMENT LANDSCAPE
  • FIGURE 44 DENTAL BONE GRAFT SUBSTITUTES MARKET: FUNDING ANALYSIS, 2019-2023
  • FIGURE 45 MOST VALUED FIRMS IN DENTAL BONE GRAFT SUBSTITUTES MARKET, 2023 (USD BILLION)
• 13.12 VALUATION AND FINANCIAL MATRICES OF DENTAL BONE GRAFT SUBSTITUTES MARKET

14 COMPANY PROFILES

• 14.1 KEY PLAYERS

(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))**

• 14.1.1 DENTSPLY SIRONA INC.
• TABLE 193 DENTSPLY SIRONA INC.: BUSINESS OVERVIEW
• FIGURE 46 DENTSPLY SIRONA INC.: COMPANY SNAPSHOT
• TABLE 194 DENTSPLY SIRONA INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
• TABLE 195 DENTSPLY SIRONA INC.: DEALS
• 14.1.2 ENVISTA HOLDINGS CORPORATION
• TABLE 196 ENVISTA HOLDINGS CORPORATION: BUSINESS OVERVIEW
• FIGURE 47 ENVISTA HOLDINGS CORPORATION: COMPANY SNAPSHOT
• TABLE 197 ENVISTA HOLDINGS CORPORATION: PRODUCTS/SERVICES/ SOLUTIONS OFFERED
• TABLE 198 ENVISTA HOLDINGS CORPORATION: PRODUCT LAUNCHES & APPROVALS
• TABLE 199 ENVISTA HOLDINGS CORPORATION: DEALS
• 14.1.3 JOHNSON & JOHNSON
• TABLE 200 JOHNSON & JOHNSON: BUSINESS OVERVIEW
• FIGURE 48 JOHNSON & JOHNSON: COMPANY SNAPSHOT
• TABLE 201 JOHNSON & JOHNSON: PRODUCTS/SERVICES/SOLUTIONS OFFERED
• TABLE 202 JOHNSON & JOHNSON: DEALS
• 14.1.4 INSTITUT STRAUMANN AG
• TABLE 203 INSTITUT STRAUMANN AG: BUSINESS OVERVIEW
• FIGURE 49 INSTITUT STRAUMANN AG: COMPANY SNAPSHOT
• TABLE 204 INSTITUT STRAUMANN AG: PRODUCTS/SERVICES/SOLUTIONS OFFERED
• TABLE 205 INSTITUT STRAUMANN AG: PRODUCT LAUNCHES & APPROVALS
• TABLE 206 INSTITUT STRAUMANN AG : DEALS
• TABLE 207 INSTITUT STRAUMANN AG: OTHER DEVELOPMENTS
• 14.1.5 MEDTRONIC, PLC
• TABLE 208 MEDTRONIC, PLC: BUSINESS OVERVIEW
• FIGURE 50 MEDTRONIC, PLC: COMPANY SNAPSHOT
• TABLE 209 MEDTRONIC, PLC: PRODUCTS/SERVICES/SOLUTIONS OFFERED
• TABLE 210 MEDTRONIC PLC: DEALS
• TABLE 211 MEDTRONIC PLC: EXPANSIONS
• 14.1.6 ZIMVIE INC.
• TABLE 212 ZIMVIE INC.: BUSINESS OVERVIEW
• FIGURE 51 ZIMVIE INC.: COMPANY SNAPSHOT
• TABLE 213 ZIMVIE INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
• TABLE 214 ZIMVIE INC: DEALS
• 14.1.7 HENRY SCHEIN, INC.
• TABLE 215 HENRY SCHEIN, INC.: BUSINESS OVERVIEW
• FIGURE 52 HENRY SCHEIN, INC.: COMPANY SNAPSHOT
• TABLE 216 HENRY SCHEIN, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
• TABLE 217 HENRY SCHEIN, INC.: PRODUCT LAUNCHES & APPROVALS
• TABLE 218 HENRY SCHEIN, INC.: DEALS
• 14.1.8 RTI SURGICAL
• TABLE 219 RTI SURGICAL: PRODUCTS/SERVICES/SOLUTIONS OFFERED
• TABLE 220 RTI SURGICAL: DEALS
• 14.1.9 LIFENET HEALTH
• TABLE 221 LIFENET HEALTH: PRODUCTS/SERVICES/SOLUTIONS OFFERED
• 14.1.10 DENTIUM CO., LTD.
• TABLE 222 DENTIUM CO., LTD.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
• 14.1.11 GEISTLICH PHARMA AG
• TABLE 223 GEISTLICH PHARMA AG: PRODUCTS/SERVICES/SOLUTIONS OFFERED
• 14.1.12 STRYKER CORPORATION
• TABLE 224 STRYKER CORPORATION: BUSINESS OVERVIEW
• FIGURE 53 STRYKER CORPORATION: COMPANY SNAPSHOT
• TABLE 225 STRYKER CORPORATION: PRODUCTS/SERVICES/SOLUTIONS OFFERED
• TABLE 226 STRYKER CORPORATION: DEALS
• 14.1.13 INTEGRA LIFESCIENCES HOLDINGS CORPORATION
• TABLE 227 INTEGRA LIFESCIENCES HOLDINGS CORPORATION: BUSINESS OVERVIEW
• FIGURE 54 INTEGRA LIFESCIENCES HOLDINGS CORPORATION: COMPANY SNAPSHOT
• TABLE 228 INTEGRA LIFESCIENCES HOLDINGS CORPORATION: PRODUCTS/SERVICES/SOLUTIONS OFFERED
• TABLE 229 INTEGRA LIFESCIENCES HOLDINGS CORPORATION: PRODUCT LAUNCHES & APPROVALS
• TABLE 230 INTEGRA LIFESCIENCES HOLDINGS CORPORATION: DEALS
• 14.1.14 TISSUE REGENIX GROUP PLC
• TABLE 231 TISSUE REGENIX GROUP PLC: BUSINESS OVERVIEW
• FIGURE 55 TISSUE REGENIX GROUP PLC: COMPANY SNAPSHOT
• TABLE 232 TISSUE REGENIX GROUP PLC: PRODUCTS/SERVICES/SOLUTIONS OFFERED
• TABLE 233 TISSUE REGENIX GROUP PLC: PRODUCT LAUNCHES & APPROVALS
• TABLE 234 TISSUE REGENIX GROUP PLC: DEALS
• TABLE 235 TISSUE REGENIX GROUP PLC: OTHER DEVELOPMENTS
• 14.1.15 KURARAY CO., LTD.
• TABLE 236 KURARAY CO., LTD.: BUSINESS OVERVIEW
• FIGURE 56 KURARAY CO., LTD.: COMPANY SNAPSHOT
• TABLE 237 KURARAY CO., LTD.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
• TABLE 238 KURARAY CO., LTD.: DEALS
• TABLE 239 KURARAY CO., LTD.: OTHER DEVELOPMENTS
• 14.1.16 BEGO GMBH & CO. KG
• TABLE 240 BEGO GMBH & CO. KG: BUSINESS OVERVIEW
• TABLE 241 BEGO GMBH & CO. KG: PRODUCTS/SERVICES/SOLUTIONS OFFERED
• TABLE 242 BEGO GMBH & CO. KG: DEALS
• 14.1.17 YOUNG INNOVATIONS
• TABLE 243 YOUNG INNOVATIONS: BUSINESS OVERVIEW
• TABLE 244 YOUNG INNOVATIONS: PRODUCTS/SERVICES/SOLUTIONS OFFERED
• TABLE 245 YOUNG INNOVATIONS: DEALS
• 14.1.18 KEYSTONE DENTAL
• TABLE 246 KEYSTONE DENTAL: BUSINESS OVERVIEW
• TABLE 247 KEYSTONE DENTAL: PRODUCTS/SERVICES/SOLUTIONS OFFERED
• TABLE 248 KEYSTONE DENTAL: DEALS
• 14.2 OTHER PLAYERS
  • 14.2.1 NOVABONE
  • 14.2.2 BOTISS BIOMATERIALS GMBH
  • 14.2.3 REGENITY
  • 14.2.4 OSTEOGENICS BIOMEDICAL
  • 14.2.5 HANNOX INTERNATIONAL CORP.
  • 14.2.6 MEYER-HAAKE GMBH
  • 14.2.7 AROA BIOSURGERY LTD.
• *Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.

15 APPENDIX

• 15.1 DISCUSSION GUIDE
• 15.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
• 15.3 CUSTOMIZATION OPTIONS
• 15.4 RELATED REPORTS
• 15.5 AUTHOR DETAILS

관련자료